Skip to content

Drug interactions

Bosentan + Ethosuximide

Severity: Moderate

Bosentan and Ethosuximide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ethosuximide is partly metabolised by CYP3A4, and bosentan is a moderate CYP3A4 inducer that may lower ethosuximide levels. This could reduce control of absence seizures.

What this interaction means in plain words

Bosentan and Ethosuximide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Bosentan belongs to Miscellaneous; Ethosuximide belongs to Central Nervous System.

Evidence level: Low

Why it happens

Induction of CYP3A4 by bosentan increases ethosuximide metabolism.

What to do

Monitor seizure control and consider ethosuximide serum concentrations after bosentan is started or stopped, adjusting the dose as needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bosentan and Ethosuximide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bosentan with Ethosuximide?

MediHelp rates the interaction as moderate. Bosentan and Ethosuximide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ethosuximide is partly metabolised by CYP3A4, and bosentan is a moderate CYP3A4 inducer that may lower ethosuximide levels. This could reduce control of absence seizures.

How serious is the interaction between Bosentan and Ethosuximide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor seizure control and consider ethosuximide serum concentrations after bosentan is started or stopped, adjusting the dose as needed.

What other medicines interact with Ethosuximide?

MediHelp also lists interactions of Ethosuximide with, for example, Benzhydrocodone / acetaminophen, Buprenorphine long-acting, Buprenorphine subdermal implant. The full list is on the Ethosuximide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in